GSK

GlobalData’s latest analysis reveals that tezepelumab, evaluated in the Phase IIa COURSE trial, achieved a 26 per cent reduction…

GlobalData’s report reveals that CGT market for GI disorders, as a standalone therapy area, is expected to increase from $47…

Serum Institute of India’s R21/Matrix-M was found to be generally safe and well-tolerated, with no serious adverse events being…

Innovative therapies targeting inflammation offer hope for improved chronic hand eczema care

2024 top biotech and pharma employers survey by Science magazine identifies leading companies in the industry

Positive mid-stage trial results push GSK's mRNA flu vaccine towards late-stage clinical development, showing enhanced immune…

GSK’s experimental herpes vaccine misses trial target, but study continues for safety monitoring and insights into recurrent…

GSK will take control of CureVac's leading experimental vaccines to fight infections, including seasonal flu and bird flu

Pharmaceutical manufacturers like Boehringer Ingelheim, GSK, and AstraZeneca are participating in this initiative

The RSV vaccine adjuvanted is currently approved for use in adults aged 60 and older and recommended by CDC/ACIP using shared…